TrademarkDir
ATHENIUM PHARMACEUTICALS
LIVE

Serial Number

76188883

Owner

Danco Investors Group, L.P.

Attorney

Robert L. Brewer

First Use Date

Mar 18, 2002

Filing Date

Jan 3, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ATHENIUM PHARMACEUTICALS Trademark

Serial Number: 76188883 • Registration: 2759532

ATHENIUM PHARMACEUTICALS is a trademark filed by Danco Investors Group, L.P. on January 3, 2001. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Danco Investors Group, L.P. (6 trademarks)

P. O. Box 150008
Nashville, TN 37215

Entity Type: 13

Trademark Details

Filing Date

January 3, 2001

Registration Date

September 2, 2003

First Use Anywhere

March 18, 2002

First Use in Commerce

March 18, 2002

Published for Opposition

March 26, 2002

Goods & Services

Pharmaceutical services, namely, drug testing and research and development

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 7, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 7, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 14, 2024 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Aug 14, 2024 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 14, 2024 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Aug 5, 2024 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Feb 24, 2024 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 24, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 31, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 2, 2022 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 19, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 19, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 19, 2021 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 19, 2013 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 19, 2013 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 19, 2013 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 10, 2013 APRE
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 4, 2013 ASCK
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Aug 30, 2013 89AF
TEAS SECTION 8 & 9 RECEIVED
Aug 30, 2013 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 14, 2009 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 12, 2009 C15A
ASSIGNED TO PARALEGAL
Sep 10, 2009 PLGL
TEAS SECTION 8 & 15 RECEIVED
Sep 2, 2009 E815
CASE FILE IN TICRS
Jul 6, 2007 CFIT
REGISTERED-PRINCIPAL REGISTER
Sep 2, 2003 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 27, 2003 CNPR
SOU TEAS EXTENSION RECEIVED
Jun 16, 2003 EEXT
STATEMENT OF USE PROCESSING COMPLETE
Dec 17, 2002 SUPC
USE AMENDMENT FILED
Dec 17, 2002 IUAF
SOU EXTENSION 1 GRANTED
Dec 17, 2002 EX1G
SOU EXTENSION 1 FILED
Dec 17, 2002 EXT1
PAPER RECEIVED
Dec 17, 2002 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 18, 2002 NOAM
PUBLISHED FOR OPPOSITION
Mar 26, 2002 PUBO
NOTICE OF PUBLICATION
Mar 6, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 3, 2001 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2001 CRFA
NON-FINAL ACTION MAILED
May 25, 2001 CNRT
ASSIGNED TO EXAMINER
May 24, 2001 DOCK

Related Trademarks

More from this Owner

ATHENIUM

ATHENIUM

ATHENIUM

ATHENIUM

ATHENIUM

ATHENIUM

ATHENIUM PHARMACEUTICALS, LLC

ATHENIUM PHARMACEUTICALS, LLC

MERCID PHARMACEUTICALS

MERCID PHARMACEUTICALS

MERCID PHARMACEUTICALS

MERCID PHARMACEUTICALS